AbCellera is breaking the barriers of conventional drug development to propel antibody-based medicines from target to clinic. We are a team of scientists, engineers, creatives, and business professionals who believe that advancing science enhances lives. We have
AbCellera Automation Engineer Job Description AbCellera is breaking the barriers of conventional antibody discovery to bring better medicines to patients, sooner. Our engine integrates expert teams, technology, and facilities with the data science and automation needed to
Senior Biological R & D Research Scientist 28 days ago Requisition ID: 1048 Senior Biological Research and Development Research Scientist Healstone Biotech was founded in 2016 by Canadian researchers at Vancouver, Canada. Healstone is the subsidiary
HOW MIGHT YOU DEFY IMAGINATION? You’ve worked hard to become the professional you are today and are now ready to take the next step in your career. How will you put your skills, experience and passion
Sr. Scientist - Multi-Specific Drug Discovery and Characterization (Contract) page is loaded Sr. Scientist - Multi-Specific Drug Discovery and Characterization (Contract) Apply remote type On Site locations Canada - Burnaby time type Full time posted on
Come be a part of a pioneering precision oncology venture, leading the charge in developing next-generation targeted radiation therapies. On the cutting edge of drug development, utilizing a unique modular technology platform to administer radioisotopes selectively,
Join an innovative precision oncology company pioneering next-generation targeted radiation therapies, a forefront in drug development. Leveraging a proprietary modular technology platform, we specialize in delivering radioisotopes to selectively eradicate tumor cells while preserving healthy tissue.
AbCellera is breaking the barriers of conventional antibody discovery to bring better medicines to patients, sooner. Our engine integrates expert teams, technology, and facilities with the data science and automation needed to propel antibody-based medicines from target to
AbCellera is breaking the barriers of conventional drug development to propel antibody-based medicines from target to clinic. We are a team of scientists, engineers, creatives, and business professionals who believe that advancing science enhances lives. We have
AbCellera is breaking the barriers of conventional antibody discovery to bring better medicines to patients, sooner. Our engine integrates expert teams, technology, and facilities with the data science and automation needed to propel antibody-based medicines from target to
AbCellera is breaking the barriers of conventional drug development to propel antibody-based medicines from target to clinic. We are a team of scientists, engineers, creatives, and business professionals who believe that advancing science enhances lives. We have
AbCellera is breaking the barriers of conventional antibody discovery to bring better medicines to patients, sooner. Our engine integrates expert teams, technology, and facilities with the data science and automation needed to propel antibody-based medicines from target to
AbCellera is breaking the barriers of conventional drug development to propel antibody-based medicines from target to clinic. We are a team of scientists, engineers, creatives, and business professionals who believe that advancing science enhances lives. We have
AbCellera is breaking the barriers of conventional antibody discovery to bring better medicines to patients, sooner. Our engine integrates expert teams, technology, and facilities with the data science and automation needed to propel antibody-based medicines from target to
AbCellera is breaking the barriers of conventional antibody discovery to bring better medicines to patients, sooner. Our engine integrates expert teams, technology, and facilities with the data science and automation needed to propel antibody-based medicines from target to
AbCellera is breaking the barriers of conventional antibody discovery to bring better medicines to patients, sooner. Our engine integrates expert teams, technology, and facilities with the data science and automation needed to propel antibody-based medicines from target to
Head of CMC Portfolio Management Full-time Vancouver, British Columbia, Canada Apply now March 15, 2024 Job ID: 23173 AbCellera is breaking the barriers of conventional antibody discovery to bring better medicines to patients, sooner. Our engine integrates